Body mass index, muscle and fat in chronic kidney disease: Questions about survival

Nephrology Dialysis Transplantation

Volumn 23, Issue 8, 2008, Pages 2461-2466

  Mafra, D ^a   Guebre Egziabher, F ^b   Fouque, D ^b  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

BMI; Haemodialysis; Muscle mass; Obesity; Survival

Indexed keywords

ADIPOSE TISSUE; BODY COMPOSITION; BODY FAT; BODY MASS; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; HEMODIALYSIS; HUMAN; INFLAMMATION; MORTALITY; MUSCLE FUNCTION; MUSCLE MASS; OBESITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SKELETAL MUSCLE; SURVIVAL; UREMIA; WORLD HEALTH ORGANIZATION;

ADIPOSE TISSUE; ADIPOSITY; BODY MASS INDEX; FEMALE; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; MALE; MUSCLE, SKELETAL; OBESITY; RISK FACTORS; SURVIVAL RATE;

EID: 48749104226     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn053     Document Type: Review

References (60)

1. Kalantar-Zadeh K, Abbott KC, Salahudeen Ak et al. Survival advantages of obesity in dialysis patients. Am J Clin Nutr 2005; 81: 543-554
2. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2005; 89: 2548-2556
3. Fouque D, Kalantar-Zadeh K, Kopple J et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 2008; 73: 391-398
4. Majchrzak KM, Pupim LB, Sundell M et al. Body composition and physical activity in end-stage renal disease. J Renal Nutr 2007; 17: 196-204
5. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363 (9403): 157-163
6. Kenchaiah S, Evans JC, Levy D et al. Obesity and the risk of heart failure. N Engl J Med 2002: 347: 305-313
7. WHO. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. WHO Technical Report Series 894. World Health Organization, Geneva, 2000.
8. Sarkar SR, Kuhlmann MK, Kotanko P et al. Metabolic consequences of body size and body composition in hemodialysis patients. Kidney Int 2006; 70: 1832-1839
9. Cook Z, Kirk S, Lawrenson S et al. Use of BMI in the assessment of undernutrition in older subjects: reflecting on practice. Proc Nutr Soc 2005; 64: 313-317
10. Watson L, Leslie W, Hankey C. Under-nutrition in old age: diagnosis and management. Rev Clin Gerontol 2006; 16: 23-34
11. Kyle UG, Genton L, Pichard C. Body composition: what's new? Curr Opin Clin Nutr Metab Care 2002; 5: 427-433
12. Sergi G, Perissinotto E, Pisent C et al. ILSA working group: an adequate threshold for body mass index to detect underweight condition in elderly persons: the Italian Longitudinal Study on Aging (ILSA). J Gerontol A Biol Sci Med Sci 2005; 60: 866-871
13. Janssen I, Katzmarzyk PT, Ross R. School of Physical and Health Education, Department of Community Health and Epidemiology, and body mass index is inversely related to mortality in older people after adjustment for waist circumference. J Am Geriatr Soc 2005; 53: 2112-2118
14. Heiat A, Vaccarino V, Krumholz HM. An evidence-based assessment of federal guidelines for overweight and obesity as they apply to elderly persons. Arch Intern Med 2001; 161: 1194-1203
15. Janssen I, Mark AE. Elevated body mass index and mortality risk in the elderly. Obes Rev 2007; 1: 41-59
16. Schooling CM, Lam TH, Li ZB et al. Obesity, physical activity, and mortality in a prospective Chinese elderly cohort. Arch Intern Med 2006; 166: 1498-1504
17. Calle EE, Thun MJ, Petrelli JM et al. Body-mass index and mortality in a prospective cohort of US adults. N Engl J Med 1999; 341: 1097-1105
18. Gelber RP, Kurth T, Manson JE et al. Body mass index and mortality in men: evaluating the shape of the association. Int J Obes (Lond) 2007; 31: 1240-1247
19. Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752
20. Wellens RI, Roche AF, Khamis HJ et al. Relationships between the body mass index and body composition. Obes Res 1996; 4: 35-44
21. See R, Abdullah SM, McGuire DK et al. The association of differing measures of overweight and obesity with prevalent atherosclerosis. The Dallas Heart Study. J Am Coll Cardiol 2007; 50: 752-759
22. Galal W, van Domburg RT, Feringa HH et al. Relation of body mass index to outcome in patients with known or suspected coronary artery disease. Am J Cardiol 2007; 99: 1485-1490
23. Schmidt D, Salahudeen A. The obesity-survival paradox in hemodialysis patients: why do overweight hemodialysis patients live longer? Nutr Clin Pract 2007; 22: 11-15
24. Praga M, Morales E. Obesity, proteinuria and progression of renal disease. Curr Opin Nephrol Hypertens 2006; 15: 481-486
25. Iseki K. Body mass index and the risk of chronic renal failure: the Asian experience. Contrib Nephrol 2006; 151: 42-56
26. Hsu, C-Y, McCulloch CE, Iribarren C et al. Body mass index and risk for end-stage renal disease. Ann Intern Med 2006; 144: 21-28
27. Nguyen S, Hsu CY. Excess weight as a risk factor for kidney failure. Curr Opin Nephrol Hypertens 2007; 16: 71-76
28. Lo JC, Go AS, Chandra M et al. GFR, body mass index, and low high-density lipoprotein concentration in adults with and without CKD. Am J Kidney Dis 2007; 50: 552-558
29. Caravaca F, Martín MV, Barroso S et al. Obesity and mortality in advanced chronic renal failure patients. Nefrologia 2004; 24: 453-462
30. Kalantar-Zadeh K, Kilpatrick RD, Kuwae N et al. Re-visiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant 2005; 20: 1880-1888
31. Kalantar-Zadeh K, Kopple JD. Obesity paradox in patients on maintenance dialysis. Contrib Nephrol 2006; 151: 57-69
32. Mafra D, Farage NE, Azevedo DL et al. Impact of serum albumin and body-mass index on survival in hemodialysis patients. Int Urol Nephrol 2007; 39: 619-624
33. Kalantar-Zadeh K, Kuwae N, Wu DY et al. Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr 2006; 83: 202-210
34. Kalantar-Zadeh K, Koople JD, Kilpratrick RD et al. Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis populations. Am J Kidney Dis 2005; 46: 489-500
35. Nurmohamed SA, Nube MJ. Reverse epidemiology. Paradoxical observations in haemodialysis patients. Neth J Med 2005; 63: 376-381
36. McDonald SP, Collins JF, Johnson DW. Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations. J Am Soc Nephrol 2003; 14: 2894-2901
37. Pliakogiannis T, Trpeski L, Taskapan H et al. Reverse epidemiology in peritoneal dialysis patients: the Canadian experience and review of the literature. Int Urol Nephrol 2007; 39: 281-288
38. Lindsted KD, Singh PN. Body mass and 26-year risk of mortality among women who never smoked: findings from the Adventist mortality study. Am J Epidemiol 1997; 146: 1-11
39. Manson JE, Stampfer MJ, Hennekens CH et al. Body weight and longevity. A reassessment. JAMA 1987; 257: 353-358
40. Mutsert R, Snijder MB, Van Der Sman-de Beer F et al. Association between body mass index and mortality is similar in the hemodialysis population and the general population at high age and equal duration of follow-up. J Am Soc Nephrol 2007; 18: 967-974
41. Stevens J, Juhaeri Cai J. Changes in body mass index prior to baseline among participants who are ill or who die during the early years of follow-up. Am J Epidemiol 2001; 153: 946-953
42. Kotanko P, Thijssen S, Kitzler T et al. Size matters: body composition and outcomes in maintenance hemodialysis patients. Blood Purif 2007; 25: 27-30
43. Beddhu S, Pappas LM, Ramkumar N et al. Effects of body size and body composition on survival in hemodialysis patients. J Am Soc Nephrol 2003; 14: 2366-2372
44. Wolfe R. The underappreciated role of muscle in health and disease. Am J Clin Nutr 2006; 84: 475-482
45. Ikizler TA, Wingard RL, Harvell J et al. Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: a prospective study. Kidney Int 1999; 55: 1945-1951
46. Ikizler TA. Protein and energy intake in advanced chronic kidney disease: how much is too much? Semin Dial 2007; 20; 5-11
47. Gregory R Adams, Nosratola D Vaziri. Skeletal muscle dysfunction in chronic renal failure: effects of exercise. Am J Physiol Renal Physiol 2006; 290: F753-F761
48. Adey D, Kumar R, McCarthy JT et al. Reduced synthesis of muscle proteins in chronic renal failure. Am J Physiol Endocrinol Metab 2000; 278: E219-E225
49. Ikizler TA, Pupim LB, Brouillette JR et al. Hemodialysis stimulates muscle and whole body protein loss and alters substrate oxidation. Am J Physiol Endocrinol Metab 2002; 282: E107-E116
50. Terrier N, Jaussent I, Dupuy A-M et al. Creatinine index and transthyretin as additive predictors of mortality in haemodialysis patients. Nephrol Dial Transplant 2008; 23: 345-353
51. Honda H, Qureshi AR, Axelsson J et al. Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality. Am J Clin Nutr 2007; 86: 633-638
52. Juge-Aubry CE, Henrichot E, Meier CA. Adipose tissue: a regulator of inflammation. Best Pract Res Clin Endocrinol Metab 2005; 19: 547-566
53. Guerre-Millo M. Adipose tissue secretory function: implication in metabolic and cardiovascular complications of obesity. J Soc Biol 2006; 200: 37-43
54. Fischer-Posovszky P, Wabitsch M, Hochberg Z. Endocrinology of adipose tissue - an update. Horm Metab Res 2007; 39: 314-321
55. Ronti T, Lupattelli G, Mannarino E. The endocrine function of adipose tissue: an update. Clin Endocrinol 2006; 64: 355-365
56. Diamant M, Lamb HJ, van de Ree MA et al. The association between abdominal visceral fat and carotid stiffness is mediated by circulating inflammatory markers in uncomplicated type 2 diabetes. J Clin Endocrinol Metab 2005; 90: 1495-1501
57. Bays H, Blond L, Rosenson R. Adiposopathy: how do diet, exercise, weight loss, drugs therapies improve metabolic disease in overweight patients? Expert Rev Cardiovasc Ther 2006; 4: 871-895
58. Axelsson J, Møller HJ, Witasp A et al. Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD. Am J Kidney Dis 2006; 48: 916-925
59. Soubassi LP, Papadakis ED, Theodoropoulos IK et al. Incidence and risk factors of coronary artery disease in patients on chronic hemodialysis. Int J Artif Organs 2007; 30: 253-257
60. Kalantar-Zadeh K, Horwich TB, Oreopoulos A et al. Risk factor paradox in wasting diseases. Curr Opin Clin Nutr Metab Care 2007; 10: 433-442